drugset

drugset / Trial / NCT05804305

Misoprostol for NASH

NCT05804305 ↗

Phase 2 Completed 50 enrolled Ziauddin University Nabiqasim Industries (Pvt) Ltd · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this randomised control trial is to evaluate the effect of Misoprostol in treating patients with NASH.

Timeline

Start: 2022-07-01
Primary completion: 2022-12-31
Completion: 2022-12-31

Publications

Siyal M, Abbas Z, Qadeer MA, Saeed A, Ali U, Khatoon A. Misoprostol for non-alcoholic steatohepatitis: a randomised control trial. BMJ Open Gastroenterol. 2024 Jun 6;11(1):e001342. doi: 10.1136/bmjgast-2023-001342.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Misoprostol	Other / unclassified	200 ug	—

Indications